Biotech

All Articles

ProKidney stops phase 3 trial certainly not required for cell therapy confirmation

.ProKidney has actually stopped among a set of period 3 trials for its own tissue treatment for kidn...

Vaxcyte surges on 'spectacular' 31-valent PCV gain versus Pfizer

.Vaxcyte unveiled what professionals called "spectacular" period 1/2 records for its 31-valent pneum...

Recursion's mind health condition test presents insufficient evidence of efficacy

.Recursion has actually discovered via a very early exam of its own tech-enabled approach to drug re...

Acepodia, Pfizer click on all together for chemistry-based tissue treatment

.Contact it an instance of good chemistry: Acepodia, a biotech based on Nobel Prize-winning scientif...

Praxis epilepsy drug decreases confiscations in stage 2 trial

.Praxis Precision Medicines has actually scored an additional midphase gain in epilepsy this year, a...

Three execs resign as Dyne blog posts mixed records for DMD prospect

.After leaving a scientific grip a number of years back, Dyne Therapy has exposed brand new period 1...

Arrowhead fires off phase 3 data in unusual metabolic ailment in advance of market clash with Ionis

.Arrowhead Pharmaceuticals has actually revealed its hand in advance of a prospective face-off along...

Pfizer, Valneva present lyme disease try helpful for 2nd enhancer

.Pfizer and Valneva may possess concerning 2 even more years to wait before they create the 1st conf...

Fierce Biotech Editor-in-Chief Ayla Ellison Chats Patronize Michelle Benz on the Future of Biotech.

.Permit's study a conversation with Ayla Ellison, Ferocious Biotech Editor-in-Chief and also Michell...

New data show how Bayer's asundexian fell short to avoid strokes

.Bayer suspended the phase 3 test for its aspect XIa inhibitor asundexian behind time in 2013 after ...